Close

Amarin (AMRN) Files Suit Against FDA Related to Off-Label Promotion

May 7, 2015 4:18 PM EDT Send to a Friend
Amarin Corp plc (NASDAQ: AMRN) and four independent physicians, in support of improved patient care, filed a lawsuit to permit ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login